Sana Biotechnology (SANA) is back in focus after Mayo Clinic agreed to collaborate on SC451 for type 1 diabetes and invest up to US$50 million, linking clinical expertise with fresh capital support.

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company's senior executives ...

Adrian Woolfson discusses "artivolution," the future of engineered species, and the implications for humanity and nature.

In the book, “Priority Technologies,” MIT faculty analyze how the U.S. can move ahead in multiple key industrial sectors — semiconductors, biotechnology, critical minerals, drones, quantum computing, ...

The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...

The Ministry of Science and ICT (MSIT) and the Ministry of Foreign Affairs held the 'Korea-Vietnam Science, Technology and ...

Strategic M&A remains a core pillar, with the pending Masimo acquisition identified as a typical Danaher deal focused on ...

Wall Street Journal bestselling author, Italian-American singer-songwriter, and gene therapy entrepreneur Patrick Girondi will appear at the Oxford Exchange Book Fair in Tampa on April 23, 2026, from ...

Dr. William A. Haseltine is a distinguished scientist, philanthropist, author, and entrepreneur renowned for his pioneering work in genomics and regenerative medicine. A former Harvard Medical School ...

Q1 2026 Earnings Call April 21, 2026 8:00 AM EDTCompany ParticipantsRachel VatnsdalRainer Blair - President, CEO ...

Margaret Atwood’s name resurfaces whenever governments tighten their grip, freedoms are curtailed or science ventures a ...

The first time Eshani Surya wrote about her ulcerative colitis was for a writing class assignment at NYU. She began the short ...